Comparison of the reliability and validity of four contemporary risk stratification schemes to predict thromboembolism in non-anticoagulated patients with atrial fibrillation

Camm, 2010, Guidelines for the management of atrial fibrillation, Eur Heart J, 31, 2369, 10.1093/eurheartj/ehq278 Fuster, 2011, J Am Coll Cardiol, 57, e101, 10.1016/j.jacc.2010.09.013 Gage, 2004, Selecting patients with atrial fibrillation for anticoagulation: stroke risk stratification in patients taking aspirin, Circulation, 110, 2287, 10.1161/01.CIR.0000145172.55640.93 Pearce, 2000, Assessment of three schemes for stratifying stroke risk in patients with nonvalvular atrial fibrillation, Am J Med, 109, 45, 10.1016/S0002-9343(00)00440-X Go, 2000, Implications of stroke risk criteria on the anticoagulation decision in nonvalvular atrial fibrillation: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study, Circulation, 102, 11, 10.1161/01.CIR.102.1.11 1994, Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation: analysis of pooled data from 5 randomized controlled trials, Arch Intern Med, 154, 1449, 10.1001/archinte.1994.00420130036007 Hart, 1999, Factors associated with ischemic stroke during aspirin therapy in atrial fibrillation: analysis of 2012 participants in the SPAF I-III clinical trials, Stroke, 30, 1223, 10.1161/01.STR.30.6.1223 Wang, 2003, A risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community: the Framingham Heart Study, JAMA, 290, 1049, 10.1001/jama.290.8.1049 Fuster, 2006, ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation—executive summary, Circulation, 114, e257, 10.1161/CIRCULATIONAHA.106.177031 Singer, 2008, American College of Chest PhysiciansAntithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition), Chest, 133, 546S, 10.1378/chest.08-0678 2008, Comparison of 12 risk stratification schemes to predict stroke in patients with nonvalvular atrial fibrillation, Stroke, 39, 1901, 10.1161/STROKEAHA.107.501825 Lip, 2010, Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation, Chest, 137, 263, 10.1378/chest.09-1584 García-Castelo, 2010, Prognostic impact of atrial fibrillation progression in a community study, Int J Cardiol, 153, 68, 10.1016/j.ijcard.2010.08.042 Fang, 2008, ATRIA Study Group. Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation, J Am Coll Cardiol, 51, 810, 10.1016/j.jacc.2007.09.065 Lip, 2010, Identifying patients at high risk for stroke despite anticoagulation: a comparison of contemporary stroke risk stratification schemes in an anticoagulated atrial fibrillation cohort, Stroke, 41, 2731, 10.1161/STROKEAHA.110.590257 Pencina, 2008, Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond, Stat Med, 27, 157, 10.1002/sim.2929 Connolly, 2007, Challenges of establishing new antithrombotic therapies in atrial fibrillation, Circulation, 116, 449, 10.1161/CIRCULATIONAHA.107.695163 Lip, 2010, Improving stroke risk stratification in atrial fibrillation, Am J Med, 123, 484, 10.1016/j.amjmed.2009.12.013 Palareti, 2009, Bleeding with anticoagulation therapy—who is at risk, and how best to identify such patients, Thromb Haemost, 102, 268, 10.1160/TH08-11-0730 Choudhry, 2006, Impact of adverse events on prescribing warfarin in patients with atrial fibrillation: matched pair analysis, BMJ, 332, 141, 10.1136/bmj.38698.709572.55